Development of oral microencapsulated forms for delivering viral vaccines

Expert Review of Vaccines

Volumn 1, Issue 3, 2002, Pages 385-397

  Nechaeva, Elena ^a  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

Author keywords

Immune system; Microencapsulation; Mucosal secretory immunity; pH dependent polymer viruses; Viral vaccines

Indexed keywords

BACTERIAL ANTIGEN; BILE ACID; BIOPOLYMER; DNA VACCINE; INFLUENZA VACCINE; PROTEINASE; RECOMBINANT VACCINE; SODIUM CHLORIDE; VIRUS ANTIGEN; VIRUS VACCINE;

ACIDITY; ANIMAL MODEL; BIODEGRADABILITY; CYTOMEGALOVIRUS; DATA ANALYSIS; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLUENZA; INTESTINE MUCOSA; MEDICAL RESEARCH; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW; RNA VIRUS INFECTION; ROTAVIRUS; STOMACH JUICE; VIRUS INFECTION; VIRUS PARTICLE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; CAPSULES; CHITIN; CHITOSAN; DRUG COMPOUNDING; HUMANS; IMMUNITY, MUCOSAL; LACTIC ACID; POLYGLYCOLIC ACID; POLYMERS; VIRAL VACCINES;

EID: 0038330616     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.1.3.385     Document Type: Review

References (57)

1. Kaiserlian D, Etchart N. Entry sites for oral vaccines and drugs: A role for M cells, enterocytes and dendritic cells. Semin. Immunol. 11, 217-224 (1999).
2. Sasaki S, Kahari S, Homajima K et al. Induction of systemic and mucosal immune responses to human immunodeficiency virus Type I by a DNA im. and intranasal routes. J. Virol. 72(6), 4931-4939 (1998).
3. McGhee J, Mestecky J, Derzbaugh M, Eldridge J. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10(2), 75-85 (1992).
4. Abraham E. Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response. Vaccine 10(7), 461-468 (1992).
5. Cryz S. Safety and immunogenicity of virosomal influenza vaccine coadministered with E. coli heat-labile toxin in healthy adults. IBC Annual Conference on Mucosal Immunization, Washington, DC, USA, 2 (1998).
6. Richards C, Hill T, Williams N. Enhancement of the immune response to non-replicating herpes simplex virus type-1 preparations by mucosal administration in the presence of cholera toxin. Vaccine 15, 1065-1069 (1997).
7. Petrov R, Zhdanov V, Kabanov V et al. Vaccinating effect of the conjugates of influenza virus surface antigens with a synthetic polymeric carrier. Dokl. Akad. Nauk SSSR 277 (3), 752-755 (1984).
8. Eldridge J, Staas J, McGhee J. Biodegradable microspheres as a vaccine delivery systems. Mol. Immunol. 28(3), 287-294 (1991).
9. Eldridge J, Staas J, Chen D, Marx P, Tice T, Gilley K. New advances in vaccine delivery systems. Semin. Hematol. 30(4), 16-24 (1993).
10. Jepson M, Simmons N, Savidge T, James P, Hirst B. Selective binding and transcytosis of latex microspheres by rabbit intestinal M cells. Cell Tissue Res. 271(3), 399-405 (1993).
11. Damge C, Aprahamian M, Marchais H, Benoit J, Pinget M. Intestinal absorption of PLGA microspheres in the rat. J. Anat. 189(3), 491-501 (1996).
12. Lomotan E, Brown K, Speaker T, Offit P. Aqueous-based microcapsules are detected primarily in gut associated dendritic cells after oral inoculation of mice. Vaccine 15 (17/18), 1959-1962 (1997).
13. Brubacker J, Patie R, Speaker T, Offit P. A quantitative luminescence assay for measuring cell uptake of aqueous-based microcapsules in vivo. J. Immunol. Methods 237, 85-93 (2000).
14. Challacombe S, Rahman D, O'Hagan D. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles. Vaccine 15(2), 169-175 (1997).
15. Sturesson C, Wikingsson L. Comparison of poly(acryl starch) and poly(lactide-coglycolide) microspheres as drug delivery system for a rotavirus vaccine. J. Controlled Release 68, 441-450 (2000).
16. Tabato Y, Inoue Y, Ikada Y. Size effect on systemic and mucosal immune responses, induced by oral administration of biodegradable microspheres. Vaccine 14(17-18), 1677-1686 (1996).
17. Mestecky J, Moldoveanu L, Novak M. et al Biodegradable microspheres for the delivery of oral vaccines. J. Control Release 28, 131-141 (1994).
18. Moldoveanu L, Novak M, Hauny W et al. Oral immunization with influenza virus in biodegradable microspheres. J. Infect. Dis. 167, 84-90 (1993).
19. Hilbert A, Fritzsche U, Kissel T. Biodegradable microspheres containing influenza A vaccine: immune response in mice. Vaccine 17(9-10), 1065-1073 (1999).
20. Cattaraj S, Rathinavelu A, Das S. Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice. J. Control Release 58(2), 223-232 (1999).
21. Palinko-Boro E, Ronaszeki G, Merkle H, Gander B. Release kinetics and immunogenicity of parvovirus microencapsulated in PLA/PLGA microspheres. Int. J. Pharm. 221(1-2), 153-157 (2001).
22. Greenway T, Eldridge J, Ludwig G, Staas J. et al. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine. Vaccine 13(15), 1411-1420 (1995).
23. Greenway T, Eldridge J, Ludwig G, Staas J. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine. Vaccine 16(13), 1314-1323 (1998).
24. Ray R, Novak M, Duncan J, Matsuoka Y. Microencapsulated human parainfluenza virus induces a protective immune response. J. infect. Dis. 167(3), 752-755 (1993).
25. Moyniham J, Jones D, Farrar G, Howard C. A novel microencapsulated peptide vaccine against hepatitis B. Vaccine 19(23-24), 3292-3000 (2001).
26. Uchida T, Shiosaki K, Nakada Y, Fukada K Microencapsulation of hepatitis B core antigen for vaccine preparation. Pharm. Res. 15(11), 1708-1713 (1998).
27. Partidos C, Vohra P, Jones D, Farrar G, Steward M. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles. J. Immunol. Merth. 206, 143-151 (1997).
28. Partidos C, Vohra P, Jones D, Farrar G, Steward M. Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles. J. Control Release 62 (3), 325-332 (1999).
29. Olszewska W, Erume J, Riplley J, Steward M, Partidos C. Immune responses and protection induced by mucosal and systemic immunization with recombinant measles nucleoprotein in a mouse model of measles virus-induced encephalitis. Arch. Virol. 146(2), 293-302 (2001).
30. Kuntz R, Saltzman W. Polymer controlled delivery for immunization. TIBTECH, 15, 364-369 (1997).
31. Cleland J, Lim A, Daugherty A, Barron L. Development of a single-shot subunit vaccine for HIV-1.5 programmable in vivo autoboost and long lasting neutralizing response. J. Pharma. Sci. 87(12), 1489-1495 (1998).
32. Jones D, Conis S, McDonald S. Poly (DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 15, 814-817 (1997).
33. Jones D, Clegg J, Farrar G. Oral delivery of microencapsulated DNA vaccines. Dev. Biol. Stand. 92, 149-155 (1998).
34. Chen S, Jones D, Fynan E, Farrar G, Clegg J, Greenberg H. Protective immunity induced by oral immunization with rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72(7), 5757-5761 (1998).
35. Shroff K, Marcucci-Borges L, Winter L et al. Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration. Vaccine 18(3-4), 222-230 (1999).
36. Lee H, Park J, Kwon K. Double-walled microparticles for single shot vaccine. J. Control Release 44 (2-3), 283-293 (1997).
37. Nakaoka R, Tabata Y, Ikada Y. Potentially of gelatin microsphere as immunological adjuvant. Vaccine 13(7), 653-661 (1995).
38. Payne L, Andrianov A. Protein release from polyphosphazene matrices. Adv. Drug Deliv. Rev. 31(3), 185-196 (1998).
39. Bowersock T, Hogenesch H, Suckow M et al. Oral vaccination of animals with antigens encapsulated in alginate microspheres. Vaccine 17(13-14), 1804-1811 (1999).
40. Offit P, Khowry C, Moser C, Clark H, Kim J, Speaker T. Enhancement of rotavirus immunogenicity by microencapsulation. Virology 203, 134-143 (1994).
41. Moser C, Speaker T, Offit P. Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice. Vaccine 15 (16), 1767-1772 (1997).
42. Moser C, Speaker T, Offit P. Effect of water-based microencapsulation on protection against EDIM rotavirus challenge in mice. J. Virol. 72(5), 3859-3862 (1998).
43. Moser C, Offit P. Distribution of rotavirus-specific memory B-cells in gut-associated lymphoid tissue after primary immunization. J. Gen. Virol. 82(9), 2271 -2274 (2001).
44. Gaserod O, Smidsrod O, Skjak-Braek G. Microcapsules of alginate-chitosan. I. A quantitative study of the interaction between alginate and chitosan. Biomaterials 19(29), 1815-1825 (1998).
45. Gaserod O, Sannes A, Skjak-Braek G. Microcapsules of alginate-chitosan. II. A study of capsule stability and permeability. Biomaterials 20(8), 773-783 (1999).
46. Yan X, Khor E, Lim L. PEC films prepared from chitosan-alginate coacervation. Chem. Pharm. Bull. 48(7), 941-946 (2000).
47. Periwal S, Speaker T, Cebra J. Orally administered microencapsulated reovirus can bypass sudded, neutralizing material antibody that inhibits active immunization of neonates J. Virol. 71(4), 2844-2850 (1997).
48. Kang D, Kim P, Ko E. et al. Peroral immunization of microencapsulated human VP8 in combination with cholera toxin induces intestinal antibody response. Mol. Cell. 19(6), 609-616 (1999).
49. Nechaeva E, Varaksin N, Ryabicheva T, Sandakhchiev L, Vilesov A, Isidorov R. A method for producing microencapsulated form of the live measles vaccine for oral administration. Application for Patent of the Russian Federation No. 2001124146 (2001), priority of August 29, 2001.
50. Nechaeva E, Varaksin N, Rjabicheva T, Getmanova T, Zaitzev B, Smolina M. Development of microgranulated form of the live measles vaccine. In: Animal Cell Technology from target to market. Kluwer Academic Publishers, Dordrecht, Boston, London, 497-499 (2001).
51. Nechaeva E, Varaksin N, Rjabicheva T, Smolina M, Kolokoltsova T, Vilesov A. Approaches to microencapsulated form of the live measles vaccine. Ann. NY Acad. Sci. 944, 180-187 (2001).
52. Cahill E, Hagan D, Illium L, Bamard A et al. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles. Vaccine 13(5), 455-462 (1995).
53. Lemoine D, Desshuyteneer M, Hogge F, Preat V. Intranasal immunization against influenza virus, using polymeric particles. J. Biomater. Sci. Polym. Ed. 10(8), 805-825 (1999).
54. Eyles J, Spiers I, Williamson E, Alpar H. Analysis of local and systemic immunological responses after intratracheal, intra-nasal and intra-muscular administration of microsphere-co-encapsulated Yersinia pestis subunit vaccines. Vaccine 16(20), 2000-2009 (1998).
55. Israel Z, Gettie A, Ishizaka S et al. Combined systemic and mucosal immunization with microsphere-encapsulated inactivated simian immunodeficiency virus elicits serum, vaginal and tracheal antibody responses in female rhesus macaques. Aids Res. Hum. Retroviruses 15(12), 1121-1136 (1999).
56. Ishizaka S, Israel Z, Gettie A et al. Induction of mucosal antibody responses by microsphere-encapsulated formalin-inactivated simian immunodeficiency virus in a male urethral challenge model. Vaccine 17(22), 2817-2825 (1999).
57. Brown K, Moser C, Speaker T, Khowry C, Kim J, Offit P. Enhancement of microencapsulation of rotavirus-specific intestinal immune responses in mice assesses by enzyme-linked immunospot assay and intestinal fragment culture. J. Infect Dis. 171, 1334-1338 (1995).